Fourth Quarter Highlights
(all comparisons made to the
-
Net sales increased 9 percent to
$2.1 billion - Organic sales growth, excluding currency and acquisition effects, up 3 percent
-
Operating income down 3 percent to
$194 million -
Operating EBITDA down 1 percent to
$346 million -
Net income per diluted share up 22 percent to
$0.99 -
Adjusted net income per diluted share up 3 percent to
$0.90 -
Cash flow from operations increased by 13 percent to
$448 million -
Adjusted free cash flow increased by 37 percent to
$382 million -
Completed the strategic acquisition of
Laddawn, Inc.
Fiscal Year Highlights
(all comparisons made to fiscal year
2017)
-
Net sales increased 11 percent to an annual record of
$7.9 billion - Organic sales, excluding currency and acquisition effects, increased 1 percent
-
Operating income up 4 percent to
$761 million -
Operating EBITDA up 4 percent to
$1,380 million -
Net income per diluted share up 43 percent to
$3.67 -
Adjusted net income per diluted share up 10 percent to
$3.37 -
Cash flow from operations increased by 3 percent to
$1,004 million -
Adjusted free cash flow increased by 5 percent to
$634 million -
Expect fiscal year 2019 cash flow from operations of
$1.04 billion and adjusted free cash flow of$670 million
Commenting on the quarter,
“Specifically by segment, our Consumer Packaging division delivered strong organic sales growth of 8 percent in the quarter, which was led by our foodservice products. These results were driven by stronger demand at quick service restaurants and convenience stores along with stronger overall end market demand for certain products. Within our Health, Hygiene & Specialties division we recorded strong quarterly sales growth of 21 percent as well as a 16 percent improvement in Operating EBITDA, including the impact of the recently completed acquisition of Clopay. Inside our Engineered Materials division, we successfully completed the acquisition of Laddawn, which enhances our ability to service the faster growing small and medium size customer base.”
Mr. Salmon continued, “As we disclosed last quarter, our Board of
Directors approved a new
Consolidated Overview | ||||||||||||
September Quarter | ||||||||||||
(in millions of dollars) | Current | Prior | $ Change | % Change | ||||||||
Net sales | $2,054 | $1,881 | $173 | 9 % | ||||||||
Operating income | 194 | 199 | (5) | (3)% | ||||||||
The net sales increase of
The operating income decrease of
Fiscal Year 2018 Results
Consolidated Overview | ||||||||||||
Fiscal Year | ||||||||||||
(in millions of dollars) | 2018 | 2017 | $ Change | % Change | ||||||||
Net sales | $7,869 | $7,095 | $774 | 11% | ||||||||
Operating income | 761 | 732 | 29 | 4% | ||||||||
The net sales growth of
The operating income increase of
Engineered Materials | ||||||||||||
Fiscal Year | ||||||||||||
(in millions of dollars) | 2018 | 2017 | $ Change | % Change | ||||||||
Net sales | $2,672 | $2,375 | $ 297 | 13% | ||||||||
Operating income | 368 | 316 | 52 | 16% | ||||||||
Net sales in the Engineered Materials segment grew by
The operating income increase of
Health, Hygiene, & Specialties | ||||||||||||
Fiscal Year | ||||||||||||
(in millions of dollars) | 2018 | 2017 | $ Change | % Change | ||||||||
Net sales | $2,734 | $2,369 | $365 | 15% | ||||||||
Operating income | 202 | 216 | (14) | (6)% | ||||||||
Net sales in the Health, Hygiene & Specialties segment grew by
The operating income decrease of
Consumer Packaging | ||||||||||||
Fiscal Year | ||||||||||||
(in millions of dollars) | 2018 | 2017 | $ Change | % Change | ||||||||
Net sales | $2,463 | $2,351 | $112 | 5 % | ||||||||
Operating income | 191 | 200 | (9) | (5)% | ||||||||
Net sales in the Consumer Packaging segment grew by
The operating income decrease of
Cash Flow and Capital Structure
Our cash flow from operating activities was
Our total debt less cash and cash equivalents at the end of the
Share Repurchase Program
In the
Outlook
We anticipate our fiscal year 2019 cash flow from operations and
adjusted free cash flow to be
Investor Conference Call
The Company will host a conference call today,
About Berry
Non-GAAP Financial Measures
This press release includes non-GAAP financial measures such as
operating EBITDA, adjusted EBITDA, adjusted net income, adjusted free
cash flow, and organic sales growth. A reconciliation of these non-GAAP
financial measures to comparable measures determined in accordance with
accounting principles generally accepted in
Forward Looking Statements
Statements in this release that are not historical, including statements relating to the expected future performance of the Company, are considered “forward looking” and are presented pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.You can identify forward-looking statements because they contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “anticipates,” “outlook,” or “looking forward,” or similar expressions that relate to our strategy, plans, or intentions.All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates, and financial results or to our expectations regarding future industry trends are forward-looking statements.In addition, we, through our senior management team, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments.These forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected.
Important factors that could cause actual results to differ
materially from our expectations, which we refer to as cautionary
statements, are disclosed under “Risk Factors” and elsewhere in our
Annual Report on Form 10-K and subsequent filings with the
Berry Global Group, Inc. |
||||||||||||||||
Quarterly Period Ended | Fiscal Year Ended | |||||||||||||||
September 29, |
September 30, |
September 29, |
September 30, |
|||||||||||||
Net sales | $ | 2,054 | $ | 1,881 | $ | 7,869 | $ | 7,095 | ||||||||
Costs and expenses: | ||||||||||||||||
Cost of goods sold | 1,705 | 1,514 | 6,438 | 5,691 | ||||||||||||
Selling, general and administrative | 114 | 121 | 480 | 494 | ||||||||||||
Amortization of intangibles | 38 | 41 | 154 | 154 | ||||||||||||
Restructuring and impairment charges | 3 | 6 | 36 | 24 | ||||||||||||
Operating income | 194 | 199 | 761 | 732 | ||||||||||||
Other expense (income), net | 8 | (4 | ) | 25 | 14 | |||||||||||
Interest expense, net | 64 | 66 | 259 | 269 | ||||||||||||
Income before income taxes | 122 | 137 | 477 | 449 | ||||||||||||
Income tax expense (benefit) | (11 | ) | 27 | (19 | ) | 109 | ||||||||||
Net income | $ | 133 | $ | 110 | $ | 496 | $ | 340 | ||||||||
Net income per share: | ||||||||||||||||
Basic | $ | 1.01 | $ | 0.84 | $ | 3.77 | $ | 2.66 | ||||||||
Diluted | 0.99 | 0.81 | 3.67 | 2.56 | ||||||||||||
Outstanding weighted-average shares: (in millions) | ||||||||||||||||
Basic | 131.7 | 130.6 | 131.4 | 127.6 | ||||||||||||
Diluted | 134.9 | 135.7 | 135.2 | 132.6 | ||||||||||||
Consolidated Statements of Comprehensive Income |
|||||||||||||||||
Quarterly Period Ended | Fiscal Year Ended | ||||||||||||||||
September 29, |
September 30, |
September 29, |
September 30, |
||||||||||||||
Net income | $ | 133 | $ | 110 | $ | 496 | $ | 340 | |||||||||
Currency translation | (18 | ) | 30 | (127 | ) | 34 | |||||||||||
Pension and other postretirement benefits | 4 | 25 | 3 | 38 | |||||||||||||
Interest rate hedges | 2 | 5 | 49 | 28 | |||||||||||||
Provision for income taxes | — | (12 | ) | (13 | ) | (20 | ) | ||||||||||
Other comprehensive income, net of tax | (12 | ) | 48 | (88 | ) | 80 | |||||||||||
Comprehensive income | $ | 121 | $ | 158 | $ | 408 | $ | 420 | |||||||||
Berry Global Group, Inc. |
|||||||||
September 29, |
September 30, |
||||||||
Assets: | |||||||||
Cash and cash equivalents | $ | 381 | $ | 306 | |||||
Accounts receivable, net | 941 | 847 | |||||||
Inventories | 887 | 762 | |||||||
Other current assets | 76 | 89 | |||||||
Property, plant, and equipment, net | 2,488 | 2,366 | |||||||
Goodwill, intangible assets, and other long-term assets | 4,358 | 4,106 | |||||||
Total assets | $ | 9,131 | $ | 8,476 | |||||
Liabilities and stockholders' equity: | |||||||||
Current liabilities, excluding debt | $ | 1,199 | $ | 1,101 | |||||
Current and long-term debt | 5,844 | 5,641 | |||||||
Other long-term liabilities | 654 | 719 | |||||||
Stockholders’ equity | 1,434 | 1,015 | |||||||
Total liabilities and stockholders' equity | $ | 9,131 | $ | 8,476 | |||||
Current and Long-Term Debt |
|||||||||
September 29, |
September 30, |
||||||||
(in millions of dollars) | |||||||||
Revolving line of credit | $ | — | $ | — | |||||
Term loans | 3,652 | 3,957 | |||||||
5½% Second priority notes | 500 | 500 | |||||||
6 % Second priority notes | 400 | 400 | |||||||
5⅛ % Second priority notes | 700 | 700 | |||||||
4½ % Second priority notes | 500 | — | |||||||
Debt discounts and deferred fees | (43 | ) | (48 | ) | |||||
Capital leases and other | 135 | 132 | |||||||
Total debt | $ | 5,844 | $ | 5,641 | |||||
Berry Global Group, Inc. |
|||||||||
Fiscal Year Ended | |||||||||
September 29, |
September 30, |
||||||||
Cash flows from operating activities: | |||||||||
Net income | $ | 496 | $ | 340 | |||||
Depreciation | 384 | 367 | |||||||
Amortization of intangibles | 154 | 154 | |||||||
Other, net | (13 | ) | 59 | ||||||
Working capital | (17 | ) | 55 | ||||||
Net cash from operating activities | 1,004 | 975 | |||||||
Cash flows from investing activities: | |||||||||
Additions to property, plant, and equipment | (336 | ) | (269 | ) | |||||
Proceeds from sale of assets | 3 | 6 | |||||||
Other investing activities, net | — | 4 | |||||||
Acquisitions of businesses, net of cash acquired | (702 | ) | (515 | ) | |||||
Net cash from investing activities | (1,035 | ) | (774 | ) | |||||
Cash flows from financing activities: | |||||||||
Proceeds from long-term borrowings | 498 | 495 | |||||||
Repayments on long-term borrowings | (335 | ) | (636 | ) | |||||
Proceeds from issuance of common stock | 23 | 31 | |||||||
Repurchase of common stock | (33 | ) | — | ||||||
Debt financing costs | (3 | ) | (5 | ) | |||||
Payment of tax receivable agreement | (37 | ) | (111 | ) | |||||
Net cash from financing activities | 113 | (226 | ) | ||||||
Effect of exchange rate changes on cash | (7 | ) | 8 | ||||||
Net change in cash | 75 | (17 | ) | ||||||
Cash and cash equivalents at beginning of period | 306 | 323 | |||||||
Cash and cash equivalents at end of period | $ | 381 | $ | 306 | |||||
Berry Global Group, Inc. |
|||||||||||||
Quarterly Period Ended September 29, 2018 | |||||||||||||
Consumer |
Health, Hygiene |
Engineered |
Total | ||||||||||
Net sales | $ | 648 | $ | 724 | $ | 682 | $ | 2,054 | |||||
Operating income | $ | 40 | $ | 62 | $ | 92 | $ | 194 | |||||
Depreciation and amortization | 60 | 54 | 27 | 141 | |||||||||
Restructuring and impairment charges | — | 2 | 1 | 3 | |||||||||
Other non-cash charges (1) | — | — | 1 | 1 | |||||||||
Business optimization costs (2) | 1 | 5 | 1 | 7 | |||||||||
Operating EBITDA | $ | 101 | $ | 123 | $ | 122 | $ | 346 | |||||
Quarterly Period Ended September 30, 2017 | |||||||||||||
Consumer |
Health, Hygiene |
Engineered |
Total | ||||||||||
Net sales | $ | 599 | $ | 596 | $ | 686 | $ | 1,881 | |||||
Operating income | $ | 50 | $ | 52 | $ | 97 | $ | 199 | |||||
Depreciation and amortization | 57 | 48 | 33 | 138 | |||||||||
Restructuring and impairment charges | 2 | 3 | 1 | 6 | |||||||||
Other non-cash charges (1) | 2 | 2 | 2 | 6 | |||||||||
Business optimization costs (2) | — | 1 | — | 1 | |||||||||
Operating EBITDA | $ | 111 | $ | 106 | $ | 133 | $ | 350 | |||||
(1) | Other non-cash charges primarily includes $4 million of stock compensation expense and other non-cash charges for both the September 2018 and 2017 quarters, respectively. | |
(2) | Includes integration expenses and other business optimization costs. | |
Berry Global Group, Inc. |
|||||||||||||
Fiscal Year Ended September 29, 2018 | |||||||||||||
Consumer |
Health, Hygiene |
Engineered |
Total | ||||||||||
Net sales | $ | 2,463 | $ | 2,734 | $ | 2,672 | $ | 7,869 | |||||
Operating income | $ | 191 | $ | 202 | $ | 368 | $ | 761 | |||||
Depreciation and amortization | 229 | 200 | 109 | 538 | |||||||||
Restructuring and impairment charges | 3 | 28 | 5 | 36 | |||||||||
Other non-cash charges (1) | 7 | 11 | 10 | 28 | |||||||||
Business optimization costs (2) | 1 | 11 | 5 | 17 | |||||||||
Operating EBITDA | $ | 431 | $ | 452 | $ | 497 | $ | 1,380 | |||||
Fiscal Year Ended September 30, 2017 | |||||||||||||
Consumer |
Health, Hygiene |
Engineered |
Total | ||||||||||
Net sales | $ | 2,351 | $ | 2,369 | $ | 2,375 | $ | 7,095 | |||||
Operating income | $ | 200 | $ | 216 | $ | 316 | $ | 732 | |||||
Depreciation and amortization | 231 | 184 | 106 | 521 | |||||||||
Restructuring and impairment charges | 8 | 11 | 5 | 24 | |||||||||
Other non-cash charges (1) | 10 | 12 | 12 | 34 | |||||||||
Business optimization costs (2) | — | 11 | 5 | 16 | |||||||||
Operating EBITDA | $ | 449 | $ | 434 | $ | 444 | $ | 1,327 | |||||
(1) | Other non-cash charges for the fiscal year ended September 29, 2018 includes $23 million of stock compensation expense, a $5 million inventory step up charge related to acquisitions and other non-cash charges. Other non-cash charges for the fiscal year ended September 30, 2017 primarily includes $20 million of stock compensation expense, a $5 million inventory step-up charge related to acquisitions along with other non-cash charges. | |
(2) | Includes integration expenses and other business optimization costs. | |
Berry Global Group, Inc. |
|||||||||||||||||
Quarterly Period Ended |
|
Fiscal Year |
|||||||||||||||
September 29, |
September 30, |
September 29, |
September 30, |
||||||||||||||
Net income | $ | 133 | $ | 110 | $ | 496 | $ | 340 | |||||||||
Add: other expense (income), net | 8 | (4 | ) | 25 | 14 | ||||||||||||
Add: interest expense, net | 64 | 66 | 259 | 269 | |||||||||||||
Add: income tax (benefit) expense | (11 | ) | 27 | (19 | ) | 109 | |||||||||||
Operating income | $ | 194 | $ | 199 | $ | 761 | $ | 732 | |||||||||
Add: non-cash amortization from 2006 private sale | 7 | 8 | 28 | 32 | |||||||||||||
Add: restructuring and impairment | 3 | 6 | 36 | 24 | |||||||||||||
Add: other non-cash charges (1) | 1 | 6 | 28 | 34 | |||||||||||||
Add: business optimization and other expenses (2) | 7 | 1 | 17 | 16 | |||||||||||||
Adjusted operating income (10) | $ | 212 | $ | 220 | $ | 870 | $ | 838 | |||||||||
Add: depreciation | 103 | 97 | 384 | 367 | |||||||||||||
Add: amortization of intangibles (3) | 31 | 33 | 126 | 122 | |||||||||||||
Operating EBITDA (10) | $ | 346 | $ | 350 | $ | 1,380 | $ | 1,327 | |||||||||
Cash flow from operating activities | $ | 448 | $ | 395 | $ | 1,004 | $ | 975 | |||||||||
Net additions to property, plant, and equipment | (66 | ) | (66 | ) | (333 | ) | (263 | ) | |||||||||
Payment of tax receivable agreement | — | (51 | ) | (37 | ) | (111 | ) | ||||||||||
Adjusted free cash flow (10) | $ | 382 | $ | 278 | $ | 634 | $ | 601 | |||||||||
Net income per diluted share | $ | 0.99 | $ | 0.81 | $ | 3.67 | $ | 2.56 | |||||||||
Other expense (income), net | 0.06 | (0.03 | ) | 0.18 | 0.11 | ||||||||||||
Non-cash amortization from 2006 private sale | 0.05 | 0.06 | 0.21 | 0.24 | |||||||||||||
Restructuring and impairment | 0.02 | 0.04 | 0.27 | 0.18 | |||||||||||||
Other non-cash charges (4) | (0.02 | ) | 0.01 | 0.04 | 0.10 | ||||||||||||
Business optimization costs (2) | 0.05 | 0.01 | 0.13 | 0.12 | |||||||||||||
Tax reform adjustments, net (5) | (0.21 | ) | — | (0.92 | ) | — | |||||||||||
Income tax impact on items above (6) | (0.04 | ) | (0.03 | ) | (0.21 | ) | (0.24 | ) | |||||||||
Adjusted net income per diluted share (10) | $ | 0.90 | $ | 0.87 | $ | 3.37 | $ | 3.07 | |||||||||
Fiscal Year |
|||||||||||||||||
Operating EBITDA (10) | $ | 1,380 | |||||||||||||||
Add: acquisitions (7) | 41 | ||||||||||||||||
Add: unrealized cost savings (8) | 28 | ||||||||||||||||
Adjusted EBITDA (10) | $ | 1,449 | |||||||||||||||
Estimated |
|||||||||||||||||
Cash flow from operating activities | $ | 1,036 | |||||||||||||||
Additions to property, plant, and equipment | (350 | ) | |||||||||||||||
Tax receivable agreement payment (9) | (16 | ) | |||||||||||||||
Adjusted free cash flow (10) | $ | 670 | |||||||||||||||
(1) | Other non-cash charges primarily includes $4 million of stock compensation expense and other non-cash charges for both the September 2018 and 2017 quarters, respectively. For the fiscal year ended September 29, 2018 other non-cash charges primarily includes $23 million of stock compensation expense, a $5 million inventory step up charge related to acquisitions and other non-cash charges. For the fiscal year ended September 30, 2017 other non-cash charges primarily includes $20 million of stock compensation expense, a $5 million inventory step up charge related to acquisitions and other non-cash charges. | |
(2) | Includes integration expenses and other business optimization costs. | |
(3) | Amortization excludes non-cash amortization from the 2006 private sale of $7 million and $8 million for the September 2018 and September 2017 quarters, respectively; along with $28 million and $32 million for the fiscal years ended 2018 and 2017, respectively. | |
(4) | Other non-cash charges excludes $4 million of stock compensation expense for the quarters ended September 29, 2018 and September 30, 2017, respectively. Additionally, other non-cash charges excludes $23 million and $20 million of stock compensation expense for the four quarters ended September 29, 2018 and September 30, 2017, respectively. | |
(5) | Includes $124 million of net adjustments for valuing and transition tax related to the passed tax reform legislation. | |
(6) | Income tax effects on adjusted net income is calculated using 25 percent for the September 2018 quarter and fiscal year and 32 percent for the September 2017 quarter and fiscal year. The rates used represents the Company’s expected effective tax rate for each respective period. | |
(7) | Represents Operating EBITDA for the Clopay acquisition for the period of September 30, 2017 - February 6, 2018 and the Laddawn, Inc. acquisition for the period of September 30, 2017 – August 24, 2018. | |
(8) | Primarily represents unrealized cost savings related to acquisitions. | |
(9) | Includes $16 million tax receivable agreement paid in our December 2018 quarter. | |
(10) |
Supplemental financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States (“GAAP”). These non-GAAP financial measures should not be considered as alternatives to operating or net income or cash flows from operating activities, in each case determined in accordance with GAAP. Organic sales growth excludes the impact of currency translation effects and acquisitions. These non-GAAP financial measures may be calculated differently by other companies, including other companies in our industry, limiting their usefulness as comparative measures. Berry’s management believes these non-GAAP financial measures are useful to our investors because they allow for a better period-over-period comparison of operating results by removing the impact of items that, in management's view, do not reflect our core operating performance. |
|
|
We define “adjusted free cash flow” as cash flow from operating activities less additions to property, plant, and equipment and payments under the tax receivable agreement. We believe adjusted free cash flow is useful to an investor in evaluating our liquidity because adjusted free cash flow and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s liquidity. We also believe adjusted cash flow is useful to an investor in evaluating our liquidity as it can assist in assessing a company’s ability to fund its growth through its generation of cash. |
|
|
Adjusted EBITDA is used by our lenders for debt covenant compliance purposes. We also use Adjusted EBITDA and Operating EBITDA among other measures to evaluate management performance and in determining performance-based compensation. Adjusted EBITDA and Operating EBITDA and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s performance. We also believe EBITDA and adjusted net income are useful to an investor in evaluating our performance without regard to revenue and expense recognition, which can vary depending upon accounting methods. |
|
Berry Global Group, Inc. |
|||||||||||||
Quarterly Period Ended September 29, 2018 | |||||||||||||
Consumer |
Health, Hygiene |
Engineered |
Total | ||||||||||
Organic sales growth | 8 | % | 3 | % | (2 | %) | 3 | % | |||||
Acquisition | — | 19 | % | 2 | % | 7 | % | ||||||
Currency effects | — | (1 | %) | — | (1 | %) | |||||||
Total Reported Net Sales | 8 | % | 21 | % | — | % | 9 | % | |||||
Fiscal Year 2018 | |||||||||||||
Consumer |
Health, Hygiene |
Engineered |
Total | ||||||||||
Organic sales growth | 5 | % | — | % | (1 | %) | 1 | % | |||||
Acquisition | — | 13 | % | 14 | % | 9 | % | ||||||
Currency effects | — | 2 | % | — | % | 1 | % | ||||||
Total Reported Net Sales | 5 | % | 15 | % | 13 | % | 11 | % |
Organic sales growth = volume + price/mix
View source version on businesswire.com: https://www.businesswire.com/news/home/20181115005212/en/
Source:
Berry Global Group, Inc.
Dustin Stilwell, 1+812-306-2964
IR@BerryGlobal.com